Composite Glucose and C-Peptide Endpoints Show Early Efficacy in Recent-Onset Type 1 Diabetes (T1D) Clinical Trials

被引：0
|
作者：
Jacobsen, Laura M.
Cuthbertson, David D.
Haller, Michael J.
Ismail, Heba M.
Sims, Emily K.
Gitelman, Stephen E.
Wherrett, Diane K.
Moran, Antoinette
Atkinson, Mark A.
Pugliese, Alberto
Gottlieb, Peter
Sosenko, Jay
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-825-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
825-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Assessments of Alternative C-Peptide (C-P) Endpoints for New-Onset Type 1 Diabetes (T1D) Clinical Trials
    Ismail, Heba M.
    Bundy, Brian N.
    Atkinson, Mark A.
    Moore, Wayne V.
    Haller, Michael J.
    Russell, William E.
    Gitelman, Stephen E.
    Herold, Kevan C.
    Redondo, Maria Jose
    Sosenko, Jay M.
    DIABETES, 2019, 68
  • [2] Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes
    Hagopian, William
    Ferry, Robert J., Jr.
    Sherry, Nicole
    Carlin, David
    Bonvini, Ezio
    Johnson, Syd
    Stein, Kathryn E.
    Koenig, Scott
    Daifotis, Anastasia G.
    Herold, Kevan C.
    Ludvigsson, Johnny
    DIABETES, 2013, 62 (11) : 3901 - 3908
  • [3] Early Predictors of Stimulated C-Peptide in Persons with Type 1 Diabetes (T1D)
    Dimeglio, Linda A.
    Cheng, Peiyao
    Beck, Roy W.
    Kollman, Craig
    Ruedy, Katrina
    Buckingham, Bruce A.
    Weinzimer, Stuart A.
    Slover, Robert
    Bremer, Andrew A.
    Aye, Tandy
    DIABETES, 2014, 63 : A392 - A392
  • [4] Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials
    Jacobsen, Laura M.
    Cuthbertson, David
    Bundy, Brian N.
    Atkinson, Mark A.
    Moore, Wayne
    Haller, Michael J.
    Russell, William E.
    Gitelman, Stephen E.
    Herold, Kevan C.
    Redondo, Maria J.
    Sims, Emily K.
    Wherrett, Diane K.
    Moran, Antoinette
    Pugliese, Alberto
    Gottlieb, Peter A.
    Sosenko, Jay M.
    Ismail, Heba M.
    DIABETES CARE, 2024, 47 (06) : 1048 - 1055
  • [5] An improved clinical model to predict stimulated C-peptide in children with recent-onset type 1 diabetes
    Buchanan, Kerry
    Mehdi, Ahmed M.
    Hughes, Ian
    Cotterill, Andrew
    Le Cao, Kim-Anh
    Thomas, Ranjeny
    Harris, Mark
    PEDIATRIC DIABETES, 2019, 20 (02) : 166 - 171
  • [6] T-Cell Auto Reactivity and C-Peptide at Onset of Pediatric Type 1 Diabetes (T1D)
    Buryk, Melissa A.
    Dosch, H-Michael
    Libman, Ingrid
    Cheung, Roy K.
    Arena, Vincent C.
    Huang, Yihe
    Pietropaolo, Massimo
    Becker, Dorothy J.
    DIABETES, 2013, 62 : A352 - A352
  • [7] Effect of Oral Insulin (OI) on Combined Glucose and C-Peptide Endpoints in Individuals at High-Risk for Type 1 Diabetes (T1D)
    Jacobsen, Laura M.
    Cuthbertson, David D.
    Sims, Emily K.
    Ismail, Heba M.
    Dimeglio, Linda
    Triolo, Taylor M.
    Redondo, Maria J.
    Lundgren, Markus
    Gottlieb, Peter
    Atkinson, Mark A.
    Krischer, Jeffrey
    Schatz, Desmond
    Sosenko, Jay
    DIABETES, 2021, 70
  • [8] Persistent C-Peptide Levels and Proliferative Retinopathy in Childhood-Onset Type 1 Diabetes (T1D)
    Williams, Katherine
    Costacou, Tina
    Becker, Dorothy J.
    Orchard, Trevor J.
    DIABETES, 2018, 67
  • [9] Effect of 24 Months of Optimised Glucose Control on Residual C-Peptide Secretion in Youth with New Onset Type 1 Diabetes (T1D)
    Boughton, Charlotte K.
    Ware, Julia
    Allen, Janet M.
    Wilinska, Malgorzata E.
    Hartnell, Sara
    Thankamony, Ajay
    Randell, Tabitha
    Ghatak, Atrayee
    Besser, Rachel
    Elleri, Daniela
    Trevelyan, Nicola
    Campbell, Fiona
    Sibayan, Judy
    Bailey, Ryan
    Calhoun, Peter
    Dunseath, Gareth J.
    Hovorka, Roman
    DIABETES, 2022, 71
  • [10] Hypoproliferative CD8 Effector Memory (EM) Subsets Are Linked to Preservation of C-Peptide in Alefacept-Treated Recent-Onset Type 1 Diabetes (T1D) Subjects
    Serti, Elisavet
    Diggins, Kirsten E.
    Muir, Virginia S.
    Lu, Tingting
    Balmas, Elisa
    Nepom, Gerald T.
    Long, S. Alice
    Linsley, Peter
    DIABETES, 2020, 69
12345